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Racial differences in potassium disposal.
Background. African Americans appear relatively potas-
sium (K+)-deficient compared with Caucasian Americans
whether on unregulated diets or on diets controlled for K+
content.
Methods. To determine whether extrarenal K+ disposal was
affected by race, KCl (0.5 mEq/kg in 0.9% saline) was infused
over 48 minutes to 12 African American and 12 Caucasian
American normotensive, healthy subjects. Identical infusions
were administered before and after 10 days of fixed electrolyte
intake. In addition to serum K+, glucose, insulin, renin, and al-
dosterone were measured in blood, and K+ and sodium (Na+)
in urine voided spontaneously during the infusions. Data were
analyzed using a two-factor analysis of variance (ANOVA) with
repeated measures.
Results. Basal serum K+ did not differ between races (African
American 3.97 ± 0.06 mEq/L and Caucasian American 3.98 ±
0.05, P = NS). The rise in serum K+ during the infusion and the
area under the curve of serum K+ over the 3.5 hours of obser-
vation were both greater in African American (African Amer-
ican +0.82 ± 0.07 mEq/L and Caucasian American +0.61 ±
0.06, P = 0.001; and African American 6.9 ± 0.5 units and Cau-
casian American 5.1 ± 0.6, P = 0.0012). The 10-day period of
controlled intake did not abolish these differences. Aldosterone
at baseline was lower and insulin was higher in African Amer-
icans at the end of the infusion. Urinary K+, plasma glucose,
and renin levels did not differ between African Americans and
Caucasian Americans.
Conclusion. Disposal of an intravenous (iv) K+ load is de-
creased in African Americans compared with Caucasian Amer-
icans, which may reflect decreased Na+,K+-ATPase activity in
African Americans in vivo.
Considerable evidence demonstrates that African
Americans behave as if they are relatively deficient in
K+ when compared with Caucasian Americans. Specifi-
cally, clinical and epidemiologic studies have found that
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the urinary excretion of K+ is significantly less in African
Americans both on random diets [1–5] and on diets fixed
for K+ content for several days or longer [2, 6, 7].
Potassium deficiency, moreover, causes renal sodium
retention and volume expansion [7–10], and is associated
with an increase in blood pressure [7, 11, 12]. Obversely,
K+ supplementation produces a natriuresis and a diure-
sis that is associated with a decrease in blood pressure
[13–21]. In this context, it is of particular interest that hy-
pertension is more prevalent in African Americans than
Caucasian Americans [22], and is characteristically of the
type associated with volume expansion [23–26]. Hyper-
tension in African Americans also appears to be more
responsive to treatment with K+ supplementation than it
does in Caucasian Americans [13].
The etiology of this state of relative K+ deficiency
in African Americans remains obscure. It could be a
consequence of a chronic decrease in dietary intake,
decreased net gastrointestinal absorption, diminished
cellular uptake of K+, or some combination of the
above. The present study was designed to determine
whether diminished cellular uptake of K+ might be a fac-
tor in the etiology of this relative deficiency in African
Americans.
METHODS
Subjects
Twelve African American and 12 Caucasian American
healthy, normotensive men and women between the ages
of 18 and 45 years were studied. Each racial group was
composed of seven men and five women. All subjects had
a normal serum potassium and creatinine, were taking no
medications, had a blood pressure repeatedly measured
to be less than 140/90 mm Hg, and a body mass index
(BMI) between 20 and 26 kg/m2. The exclusion criteria
were a history of renal disease, hypertension, pregnancy,
or gastrointestinal surgery or disease. Each participant
gave informed consent, and the protocol was approved
by the Institutional Review Board of Northwestern
University.
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Table 1. Baseline characteristics of study subjects
African American Caucasian American P value
Race
Sex Male Female Male Female Race Sex
N 7 5 7 5
Age 29.3 ± 3.4 26.6 ± 3.9 25.7± 1.2 26.4 ± 2.9 NS NS
Weight kg 77.2 ± 4.3 68.6 ± 4.1 77.7 ± 3.0 56.6 ± 3.4 NS 0.001
BMI kg/m2 24.5 ± 1.4 23.8 ± 1.3 22.9 ± 0.7 21.4 ± 0.9 0.093 NS
Heart rate 62.4 ± 3.5 67.1 ± 3.6 65.7 ± 7.6 72.8 ± 1.0 NS NS
Systolic BP 122 ± 3 108 ± 2 120 ± 6 110 ± 9 NS 0.027
Diastolic BP 70 ± 2 64 ± 1 69 ± 6 64 ± 5 NS NS
MAP 87.6 ± 2.5 78.7 ± 1.3 86.0 ± 5.6 79.2 ± 6.2 NS 0.074
Creatinine mg % 1.0 ± 0.1 1.1 ± 0.0 1.0 ± 0.1 0.8 ± 0.1 NS NS
Experimental protocol
Participants were admitted to the General Clinical
Research Center (GCRC) of Northwestern Memorial
Hospital. A complete history and physical examination
including weight and height was performed on each sub-
ject, blood was obtained for determination of a multi-
organ chemistry profile, and a complete blood count,
urinalysis, and urine pregnancy test (if applicable) were
performed. On the first morning (day 1) after an
overnight fast, subjects received a constant infusion of
KCl (0.5 mEq/kg body weight diluted in 450 cc of 0.9%
saline) into an antecubital vein over 48 minutes using
an IVAC pump (Alaris Infusion System, San Diego, CA,
USA). Blood samples were obtained from the opposite
arm. Serum K+ was obtained at 15-minute intervals for
one hour before the start of KCl infusion and for the
ensuing 3.5 hours. Serum insulin and glucose were ob-
tained one hour prior to the KCl infusion, at the start of
the infusion, at 60 minutes, and at 210 minutes after the
start of the infusion. Aldosterone and plasma renin ac-
tivity were measured at the start of the infusion and 3.5
hours later. Blood pressure and pulse were monitored
by automated device (Datascope, GE Marquette Medi-
cal Products, Milwaukee, WI, USA) at 10-minute inter-
vals from one hour before to 3.5 hours after the start of
the infusion. Spontaneously voided urine specimens were
collected before and during the period of observation.
Following the K+ infusion on day 1, all subjects were
placed on a diet containing 180 mEq/d of Na+, 100 mEq/d
of K+, and 150 mEq/d of Cl−. The participants received
approximately 37 to 41 kcal/kg body weight based on rec-
ommended daily allowances (RDA) set by the National
Research Council and the National Academy of Science
for weight maintenance. The participants were allowed
unlimited ingestion of electrolyte free water. Alcohol and
caffeine intake was not permitted during the duration of
the study. On the morning of day 11, the K+ infusion was
repeated following an overnight fast.
Laboratory analyses
Serum and urine Na+ and K+ were measured by ion-
specific electrodes. Aldosterone, insulin, and plasma
renin activity (PRA) were analyzed by radioimmunoas-
say, and glucose by glucose oxidase methodology in the
clinical laboratory of Northwestern Memorial Hospital.
Statistical analysis
Data are presented as mean ± SEM. Analyses for
all variables utilized a two-factor analysis of variance
(ANOVA) with race and sex as the two between-subjects
factors. In addition, data from the intravenous (iv) K+ in-
fusions were analyzed separately for day 1 and day 11
using a repeated measures ANOVA model, with time as
the within-subject factor and also in a combined analysis,
with both day and time as within-subject factors. Post-
hoc, pair-wise comparisons following ANOVA utilized
the Scheffe´ test. Goodness-of-fit was determined by ex-
amination of externally studentinized residuals. Analyses
employed P < 0.05 as the criterion for statistical signifi-
cance; P values between 0.05 and 0.1 are provided in text
and tables, while P values ≥0.1 are indicated by NS.
RESULTS
Baseline characteristics
Demographics at baseline and clinical characteristics
of the subjects are presented in Table 1. No racial differ-
ences were present in baseline variables, though BMI was
slightly but not significantly greater in African American
subjects. Female subjects weighed less and displayed a
lower systolic blood pressure than male subjects. Women
also tended to have a lower mean arterial pressure
than men, although the difference was not statistically
significant.
Effects of iv KCl on serum and urine K+
Serum K+ levels obtained before, during, and after K+
infusion are presented in Figure 1, and a summary of
the data is found in Table 2. Basal, preinfusion levels of
K+ did not differ between African American and Cau-
casian American subjects or between men and women.
Although basal serum K+ did not differ between the two
infusions on days 1 and 11, basal K+ in men and women
did increase in African American from day 1 to day 11
(from 3.89 ± 0.04 to 4.05 ± 0.07 mEq/L, P = 0.035),
though not in Caucasian American (from 3.96 ± 0.06
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Fig. 1. Effect of KCl infusion on serum K+
in African American and Caucasian Ameri-
can men and women. Identical studies were
carried out before (A) (day 1) and after (B)
(day 11) a period of controlled intake of K+,
Na+ and Cl−. Data are presented as mean ±
SE. Open circles refer to Caucasian American
subjects and closed circles to African Ameri-
can subjects.
Table 2. Summary of changes in serum K+, urine K+, and urine Na+ during KCl infusions
African American Caucasian American P value
Race
Sex Male Female Male Female Race Sex
N 7 5 7 5
Day 1
Basal K+ mEq/L 3.95 ± 0.06 3.81 ± 0.05 3.97 ± 0.09 3.94 ± 0.08 NS NS
K+ mEq/L +0.86 ± 0.08 +0.85 ± 0.15 +0.55 ± 0.08 +0.54 ± 0.09 0.005 NS
K+AUC mEq 7.12 ± 0.60 8.43 ± 0.54 4.99 ± 0.71 4.61 ± 1.21 0.001 NS
Urine K+ mEq 24.5 ± 4.2 19.1 ± 3.7 36.1 ± 6.7 27.9 ± 3.9 0.066 NS
Urine Na+ mEq 84.6 ± 16.3 54.9 ± 5.3 69.1 ± 8.6 67.4 ± 11.8 NS NS
Day 11
Basal K+ mEq/L 4.11 ± 0.11 3.96 ± 0.05 3.90 ± 0.07 3.99 ± 0.03 NS NS
K+ mEq/L +0.89 ± 0.06 +0.64 ± 0.13 +0.66 ± 0.10 +0.45 ± 0.07 0.037 0.021
K+AUC mEq 6.27 ± 0.79 5.88 ± 0.61 6.17 ± 0.60 3.27 ± 0.21 0.051 0.021
Urine K+ mEq 37.7 ± 4.0 26.9 ± 1.0 38.6 ± 5.8 27.8 ± 2.0 NS 0.021
Urine Na+ mEq 61.7 ± 5.9 46.5 ± 6.8 59.9 ± 9.0 41.2 ± 4.4 NS 0.030
to 3.94 ± 0.04 mEq/L, P = NS). The rise in serum K+
from baseline to the peak at 45 minutes was greater in all
African Americans both on day 1 (+0.86 ± 0.07 mEq/L)
and on day 11 (+0.78 ± 0.07) than in all Caucasian Amer-
icans (+0.55 ± 0.06 and +0.57 ± 0.07, days 1 and 11,
respectively; effect of race, P < 0.003 overall). The in-
crement in serum K+ was also greater overall in African
Americans at both 15 and 30 minutes following the start
of the K+ infusion (P < 0.002 and P = 0.008, respec-
tively). The elevation in serum K+ above baseline over
the 3.5 hours of the infusion study was, likewise, greater in
African Americans than in Caucasian American subjects
(P = 0.001). The area under the serum K+ curve tended
to be less on day 11 than on day 1 (P = 0.054), an effect
that was statistically greater in women than in men (P =
0.025), and slightly greater in African Americans than
in Caucasian Americans (P = 0.076). Thus, KCl infusion
raises serum K+ to a greater extent in African Americans
than in Caucasian Americans, an effect that is apparent
within the first 15 minutes of K+ infusion and persists fol-
lowing a 10-day period of controlled potassium intake.
Urine collected during the study was analyzed for K+
and Na+, and the results are presented in Table 2. Urine
K+ was slightly less in African Americans than Caucasian
Americans on day 1, but not on day 11, though overall,
urine K+ did not differ between racial groups. When com-
pared to the amount of K+ infused, the fraction excreted
was less in African Americans than Caucasian Americans
on day 1 (P = 0.009), but not on day 11. Overall, male
and female African Americans excreted 75 ± 6% of the
infused K+, while Caucasian Americans excreted 97 ±
7% (P = 0.016). Urine K+ was less in women than men
on day 11, though not on day 1, and was less in women
overall (P = 0.035). Urine Na+ did not differ between
races, and was lower overall in women than in men (P =
0.046). Urine Na+ in all subjects was less on day 11 than
on day 1 (P = 0.020).
Effects of iv KCl on glucose and insulin
Serum glucose and insulin levels obtained before and
after the two K+ infusions are presented in Table 3. Glu-
cose levels did not differ overall between races, although
they were slightly greater in African Americans on day 1.
On the other hand, insulin levels were significantly higher
in African Americans than Caucasian Americans on day
11 (P = 0.033), though not on day 1 and, overall, insulin
levels were slightly, but not significantly higher in African
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Table 3. Glucose and insulin levels during KCl infusions
African American Caucasian American P value
Race
Time −60 0 60 210 −60 0 60 210 Race Sex
Day 1
Glucose mg/dL 93.9 ± 2.6 91.6 ± 2.6 96.4 ± 5.3 87.6 ± 2.3 87.1 ± 1.8 86.8 ± 1.9 83.2 ± 1.9 85.6 ± 2.2 0.092 NS
Insulin lU/mL 13.4 ± 2.1 11.5 ± 1.9 20.7 ± 5.8 11.6 ± 1.6 11.6 ± 1.0 11.3 ± 0.9 10.4 ± 0.6 9.8 ± 0.5 NS NS
Day 11
Glucose mg/dL 86.2 ± 2.4 86.8 ± 2.1 86.1 ± 4.5 85.5 ± 1.6 83.8 ± 1.6 81.3 ± 1.6 82.3 ± 1.7 83.7 ± 2.1 NS 0.049
Insulin lU/mL 11.6 ± 1.9 11.7 ± 1.3 17.7 ± 5.8 10.4 ± 1.9 9.8 ± 0.6 9.1 ± 0.6 8.5 ± 0.6 8.6 ± 0.7 0.033 0.064
Table 4. Aldosterone levels and plasma renin activity during KCl infusions
African American Caucasian American
Race Male Female Male Female P value
Sex
Time minutes 0 210 0 210 0 210 0 210 Race Sex
Day 1
Aldosterone pg/mL 42.4 ± 15.0 35.0 ± 10.1 29.8 ± 3.8 42.3 ± 6.5 68.1 ± 11.2 60.6 ± 11.7 59.0 ± 11.7 43.8 ± 12.5 0.071 NS
PRA mEq/L 0.53 ± 0.16 0.67 ± 0.22 0.78 ± 0.15 1.02 ± 0.26 1.51 ± 0.42 1.33 ± 0.38 1.34 ± 0.47 1.05 ± 0.42 NS NS
Day 11
Aldosterone pg/mL 42.8 ± 9.0 38.6 ± 6.0 75.2 ± 24.3 68.4 ± 23.8 80.3 ± 16.4 51.2 ± 8.3 69.3 ± 5.4 50.8 ± 12.1 NS NS
PRA mEq/L 0.90 ± 0.18 0.57 ± 0.15 1.24 ± 0.32 1.15 ± 0.34 1.12 ± 0.15 1.04 ± 0.21 1.42 ± 0.40 1.01 ± 0.26 NS NS
Americans than Caucasian Americans (P = 0.077). Of
note, insulin levels, both on day 1 and day 11, were sig-
nificantly higher in African Americans than in Caucasian
Americans at 60 minutes (race × time interaction, P =
0.037), shortly after the end of the KCl infusions. More-
over, this was the only time during the studies at which
insulin levels differed between races.
Effects of iv KCl on aldosterone and renin
Serum aldosterone levels and plasma renin activity
measured at the beginning of the KCl infusion and at the
end of the 3.5-hour study are presented in Table 4. Over-
all, aldosterone levels were lower in African Americans
at baseline (P < 0.001), though not at 210 minutes (P =
NS). For plasma renin activity, baseline levels were lower
in African Americans on day 1 (race × time interaction,
P = 0.007), but not on day 11 (race × time interaction,
P = NS). Aldosterone and renin activity did not differ in
men and women.
Effects of iv KCl on MAP and heart rate
Blood pressure measurements obtained throughout
both K+ infusions are illustrated in Figure 2, and sum-
maries of mean arterial pressure (MAP) and heart rate
data are presented in Table 5. MAP rose, on average,
4.9 ± 1.0 mm Hg in all subjects during the period of KCl
infusion. This increase did not differ as a function of race,
although the increment in women was slightly less than
in men (P = 0.063). Heart rate also increased 3.9 ± 1.2
beats/min, but this rise did not differ as a function of race
or sex. Heart rate overall was higher in women than in
men (P < 0.001).
DISCUSSION
The present study demonstrates that the rate of dis-
posal of an intravenous K+ load is less in African Ameri-
can compared with Caucasian American subjects. Serum
K+ levels rose to a greater extent during the KCl infu-
sion and returned more slowly toward baseline levels in
the African American subjects. This racial difference in
K+ disposal was apparent both before and after a 10-
day period, during which all subjects consumed a diet
containing 100 mEq of K+ per day. K+ disposal was
markedly reduced in African Americans on day 1 and
was still diminished, though slightly less so, after 10 days
of equivalent dietary intake. Thus, the slower rate of K+
disposal in African American subjects does not appear
to be secondary to racial differences in the antecedent
diet.
K+ excretion in urine during the test was also slightly
lower in African American subjects. While the total
amount excreted did not differ significantly between
racial groups, the ratio of K+ present in spontaneously
voided urine to the amount of K+ infused during the
test was 23% less in African Americans than in Cau-
casian Americans, overall. A primary renal cause for the
racial difference in K+ disposal, however, is unlikely. Not
only was the difference in renal K+ excretion between
African Americans and Caucasian Americans during
each test small (5.7 mEq/test, on average), the increment
in serum K+ was demonstrably greater in African Amer-
icans as early as 15 minutes after the start of the K+ infu-
sion, well before an impairment in renal excretion would
affect the serum K+ level. Because urinary K+ excre-
tion is predominantly the result of renal tubular cell up-
take and secretion, diminished K+ excretion in African
1080 Suh et al: Racial differences in K+ disposal
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Fig. 2. Effect of KCl infusion on mean arte-
rial pressure (MAP) in African American and
Caucasian American men and women. Iden-
tical studies were carried out before (day 1)
(A) and after (day 11) (B) a period of con-
trolled intake of K+, Na+ and Cl−. Data are
presented as mean ± SE. Open circles refer to
Caucasian American subjects and closed cir-
cles to African American subjects.
Table 5. Summary of changes in MAP and heart rate during KCl infusions
African American Caucasian American P value
Race
Sex Male Female Male Female Race Sex
N 7 5 7 5
Day 1
Basal MAP mm Hg 85.7 ± 3.5 78.3 ± 1.3 83.6 ± 3.6 79.3 ± 6.2 NS NS
MAP mm Hg 7.0 ± 2.1 0.4 ± 1.4 8.3 ± 3.4 5.7 ± 2.9 NS NS
Basal HR beats/min 57.5 ± 3.1 67.4 ± 3.7 57.6 ± 3.8 73.0 ± 0.6 NS 0.001
HR beats/min 6.5 ± 2.0 7.6 ± 6.6 7.7 ± 3.0 −1.2 ± 4.6 NS NS
Day 11
Basal MAP mm Hg 84.1 ± 2.0 78.3 ± 1.9 84.6 ± 2.1 77.1 ± 6.1 NS 0.047
MAP mm Hg 6.8 ± 2.7 2.3 ± 4.9 3.6 ± 1.5 2.2 ± 2.9 NS NS
Basal HR beats/min 59.9 ± 2.6 68.8 ± 1.7 54.9 ± 2.6 66.1 ± 3.3 NS 0.001
HR beats/min 2.2 ± 0.9 −2.0 ± 3.2 5.3 ± 2.2 2.3 ± 3.5 NS NS
Americans is very likely an additional manifestation of a
general impairment in cellular K+ uptake.
If this reduction in K+ disposal in African American
men and women were not solely a consequence of racial
differences in diet or in renal excretion of K+, what might
account for this observation? Of the hormones measured
during this study, only insulin and aldosterone levels dif-
fered in African Americans and Caucasian Americans.
Although glucose levels did not differ between racial
groups, insulin levels were slightly (but not significantly)
higher overall in African Americans, and were signifi-
cantly increased in African Americans above those in
Caucasian Americans at the end of the KCl infusion on
both study days. Although hyperkalemia has been shown
previously to raise insulin levels in animals in vivo, the ele-
vation in K+ required is much greater than seen here [27].
The rise in insulin in response to K+ infusion in African
Americans is unexplained, as it is unexpected. Since in-
sulin plays an important role in the transfer of K+ into
intracellular space [28], and its effect on K+ transfer is
distinguishable from its effect on glucose uptake [29, 30],
hyperinsulinemia in African Americans following K+ in-
fusion cannot explain the racial limitation in K+ disposal.
Baseline serum aldosterone levels were lower in
African Americans than in Caucasian Americans, a
finding consistent with earlier observations [7, 31–33].
Despite the lower aldosterone level at the start of the
infusions, however, overall urinary K+ excretion during
the infusion tests was not significantly reduced in African
Americans. Although urinary excretion in relation to K+
infused was less overall in African Americans than in
Caucasian Americans, it was similar on day 11. While a
direct role for aldosterone in the uptake of K+ by skeletal
muscle is unproved [34], aldosterone does have a small,
but definite effect on colonic K+ transport mediated via
changes in Na+,K+-ATPase [35]. Consequently, a racial
difference in the sequestration of K+ in colonic fluid
might contribute to the slower rate of K+ disposal seen in
African Americans, but it is unlikely to be quantitatively
important.
CONCLUSION
Although a hormonal basis for the impact of race on
K+ metabolism is currently obscure, the predominant site
at which the observed difference in cellular K+ uptake oc-
curs is likely skeletal muscle, where K+ uptake is medi-
ated specifically by the activity of Na+,K+-ATPase. In this
context, while numerous investigators have reported that
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the activity of this enzyme is decreased in red blood cells
in vitro of African Americans compared with Caucasian
Americans [5, 36–38], no evidence of a racial difference in
Na+,K+-ATPase in skeletal muscle is currently available.
Because skeletal muscle is by far the largest repository of
K+ and Na+,K+-ATPase is the principal regulator of K+
uptake by all cells, our observations in vivo may well in-
dicate a more global reduction in activity of this enzyme
in African Americans. Whether Na+,K+-ATPase activ-
ity is in fact diminished in African Americans in vivo,
and what the etiology of such a racial difference might
be, is unclear, but further study is warranted.
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